Skip to main content
Clinical Trials/CTRI/2021/11/037924
CTRI/2021/11/037924
Recruiting
未知

Prospective evaluation of the clinical safety and effectiveness of hydrophilic acrylic intraocular lens. - UVEA 809

Carl Zeiss Meditec AG0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: H259- Unspecified age-related cataract
Sponsor
Carl Zeiss Meditec AG
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients of any gender, aged 18 years or older
  • 2\. Patient is planned for aged\-related cataract surgery and implantation of the
  • study IOL into the capsular bag in at least one eye
  • 3\. Patient is willing and capable of providing informed consent
  • 4\. Patient is willing and capable of complying with visits and procedures as
  • defined by this protocol

Exclusion Criteria

  • 1\. Preoperative corrected distance visual acuity (CDVA) better than 0\.3
  • logMAR (0\.5 decimal)
  • 2\. Endothelial cell count of less than 2000/mm2
  • 3\. Ocular disorder that could potentially cause a clinically significant future
  • visual acuity loss
  • 4\. Preoperative corneal astigmatism ââ?°Â¥ 1 D or preoperative corneal
  • astigmatism ââ?°Â¥ 1\.5 D, if postoperative corneal astigmatism is not estimated
  • to be \< 1 D.
  • 5\. Clinically significant anterior segment pathology (e.g. chronic uveitis, iritis,
  • aniridia, rubeosis iridis, anterior membrane dystrophies, poor pupil dilation,

Outcomes

Primary Outcomes

Not specified

Similar Trials